1-4 of 4
Anna R Franklin
Close
Sort by
Journal Articles

The Antibody-Drug Conjugate Brentuximab Vedotin (SGN-35) Induced Multiple Objective Responses in Patients with Relapsed or Refractory CD30-Positive Lymphomas in a Phase 1 Weekly Dosing Study.

Michelle Fanale, MD, Nancy L Bartlett, MD, Andres Forero-Torres, MD, Joseph Rosenblatt, MD, Sandra J Horning, MD, Anna R Franklin, MD, Carmel M Lynch, PhD, Eric L Sievers, MD, Dana A Kennedy, PharmD, BCOP
Journal: Blood
Blood (2009) 114 (22): 2731.
https://doi.org/10.1182/blood.V114.22.2731.2731
Published: 2009
Journal Articles

Pediatric-Based Therapy for Young Adults with Newly Diagnosed Lymphoblastic Leukemia.

Michael Rytting, M.D., Deborah A. Thomas, MD, Anna R Franklin, Elias Jabbour, William Wierda, MD, PhD, Stefan Faderl, MD, Robert Wells, MD, Tapan Kadia, MD, Farhad Ravandi, M.D., Alessandra Ferrajoli, MD., Jorge Cortes, MD, Susan O'Brien, Hagop Kantarjian, MD
Journal: Blood
Blood (2009) 114 (22): 2037.
https://doi.org/10.1182/blood.V114.22.2037.2037
Published: 2009
Journal Articles

A Therapeutic Approach for Acute Leukemias: Glycolysis Inhibition Revisited

Lauren J. Akers, DO, Alejandro G. Levy, MD, Anna R. Franklin, MD, Wendy Fang, MD, Peng Huang, PhD, Patrick Zweidler-McKay, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5020.
https://doi.org/10.1182/blood.V112.11.5020.5020
Published: 2008
Journal Articles

The Novel Glycolysis Inhibitor, 3-BrOP, Has Broad Activity Against Acute Lymphoblastic Leukemias and Potentiates Methotrexate and Rapamycin.

Lauren J. Akers, DO, Anna R. Franklin, MD, Peng Huang, MD, PhD, Patrick A. Zweidler-McKay, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4203.
https://doi.org/10.1182/blood.V110.11.4203.4203
Published: 2007